Skip to content

Home Hospital for Bariatric Sleeve Gastrectomy

Acute Care at Home for Adults Undergoing Bariatric Sleeve Gastrectomy: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05259111
Enrollment
28
Registered
2022-02-28
Start date
2022-02-23
Completion date
2024-05-24
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Sleeve Gastrectomy, Bariatric Surgery Candidate, Home Hospital

Brief summary

Providing acute care at home for medicine patients is a well-studied care model. Providing acute care at home immediately following major surgery is less well understood. The investigators seek to demonstrate the noninferiority of care at home versus the hospital for patients undergoing bariatric sleeve gastrectomy.

Interventions

OTHERHome hospital

Acute care provided at home, including nurse/paramedic visits, physician visits, laboratory testing, imaging, continuous monitoring, 24/7 urgent visits, and specialty consultation.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* All existing home hospital criteria apply, with the following taking precedent for this specific condition * 21-55 years old * Indication for bariatric laparoscopic sleeve gastrectomy per surgeon * Caregiver capable of communicating with the home hospital team and able to stay in the same home as the patient the first night the patient is home

Exclusion criteria

* All existing home hospital criteria apply, with the following taking precedent for this specific condition * Comorbidities * Body mass index\>55 * Chronic kidney disease * Heart failure * History of * Chronic pain (with or without opioid use) * Substance use disorder * Venous thromboembolism * Stroke * Chronic headache * Medications * Anticoagulants and anti-platelets: aspirin, clopidogrel, warfarin, and direct oral anticoagulants * Beta blockade * Immunosuppressive * Supplemental oxygen * Allergy to ketorolac * Prolonged QTc

Design outcomes

Primary

MeasureTime frameDescription
Length of StayFrom day of admission to day of discharge, assessed up to 10 monthsDays spent hospitalized

Secondary

MeasureTime frameDescription
MotionFrom day of admission to day of discharge, assessed up to 10 monthsPercent of the day lying down
Cost, directFrom day of admission to day of discharge, assessed up to 10 monthsPresented as a percentage
Opioid useFrom day of admission to day of discharge, assessed up to 10 monthsMorphine milligram equivalents used

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026